The medium-term impact of Medicare Part D on pharmaceutical prices

American Economic Review

Volumn 101, Issue 3, 2011, Pages 387-392

  Duggan, Mark G ^a   Morton, Fiona Scott ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b YALE SCHOOL OF MANAGEMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958262186     PISSN: 00028282     EISSN: None     Source Type: Journal    
DOI: 10.1257/aer.101.3.387     Document Type: Conference Paper

References (6)

1. Duggan, Mark, Patrick Healy, and Fiona Scott Morton. 2008. "Symposium: Health Care: Providing Prescription Drug Coverage to the Elderly: America's Experiment with Medicare Part D". Journal of Economic Perspectives, 22(4):69-92.
2. Duggan, Mark, and Fiona Scott Morton. 2010. "The Effect of Medicare Part D on Pharmaceutical Prices and Utilization". American Economic Review, 100(1):590-607.
3. Duggan, Mark, and Fiona Scott Morton. 2006. "The Distortionary Effects of Government Procurement: Evidence from Medicaid Prescription Drug Purchasing". Quarterly Journal of Economics, 121(1):1-30. (Pubitemid 43374414)
4. Hargrave, Elizabeth, Jack Hoadley, Laura Summer, Juliette Cubanski, and Tricia Neuman. 2010. "Medicare Part D Data Spotlight: Coverage of Top Brand-Name and Specialty Drugs". Kaiser Family Foundation. http://kff.org/medicare/upload/8095.pdf.
5. Hoadley, Jack, Juliette Cubanski, Elizabeth Hargrave, Laura Summer, and Tricia Neuman. 2010. "Medicare Part D Spotlight: Part D Plan Availability in 2011 and Key Changes Since 2006". Kaiser Family Foundation. http://www.kff.org/medicare/upload/8107.pdf.
6. Lakdawalla, Darius, and Wesley Yin. 2010. "Insurers' Negotiating Leverage and the External Effects of Medicare Part D". Unpublished.